
Researchers could use the findings to better understand the genetic influences on health and disease

The announcement follows President Biden signing the Accelerating Access to Critical Therapies for ALS Act in December 2021
Joshua Yang, Co-founder & CEO of Glyphic Biotechnologies and Co-founder of NephroSant, dives into next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and...
Say Communications, healthcare PR agency, analyses the prospect of living to 150 years old, thanks to the anti-ageing biomedical research, and what PR will look like.

Will research immunotherapies, imaging and stem cell treatments